| Literature DB >> 34314418 |
Luigi Fontana1,2,3, Alessio Fasano4,5, Yap Seng Chong6,7, Paolo Vineis8, Walter C Willett9,10.
Abstract
Modern medicine makes it possible for many people to live with multiple chronic diseases for decades, but this has enormous social, financial, and environmental consequences. Preclinical, epidemiological, and clinical trial data have shown that many of the most common chronic diseases are largely preventable with nutritional and lifestyle interventions that are targeting well-characterized signaling pathways and the symbiotic relationship with our microbiome. Most of the research priorities and spending for health are focused on finding new molecular targets for the development of biotech and pharmaceutical products. Very little is invested in mechanism-based preventive science, medicine, and education. We believe that overly enthusiastic expectations regarding the benefits of pharmacological research for disease treatment have the potential to impact and distort not only medical research and practice but also environmental health and sustainable economic growth. Transitioning from a primarily disease-centered medical system to a balanced preventive and personalized treatment healthcare system is key to reduce social disparities in health and achieve financially sustainable, universal health coverage for all. In this Perspective article, we discuss a range of science-based strategies, policies, and structural reforms to design an entire new disease prevention-centered science, educational, and healthcare system that maximizes both human and environmental health.Entities:
Mesh:
Year: 2021 PMID: 34314418 PMCID: PMC8315511 DOI: 10.1371/journal.pmed.1003699
Source DB: PubMed Journal: PLoS Med ISSN: 1549-1277 Impact factor: 11.069
Fig 1Most prevalent chronic diseases share a common metabolic substrate.
The unhealthy lifestyle effectors, including excessive calorie intake, poor diets, sedentary lifestyle, mental stress, smoking, and pollution, modulate important metabolic and hormonal factors associated with the development of the most common age-associated chronic diseases. Abdominal obesity is a central node, but many effects of these unhealthy lifestyle are mediated through other metabolic and inflammatory pathways as well. IGFBP1, insulin-like growth factor-binding protein 1; NAFLD, nonalcoholic fatty liver disease; SHBG, sex hormone–binding globulin.